Publications by authors named "A Gouliaev"
Introduction: This study aimed to evaluate the consistency of lung cancer case assessments across multidisciplinary team (MDT) sites in Denmark. The goal was to appraise the comparability of outcomes between hospitals in a real-world context.
Methods: We prepared sixty comprehensive, fictitious lung cancer case stories, complete with images, and distributed them to the four primary lung cancer MDT conferences in Denmark.
Background: Long-term survival of patients with non-small cell lung cancer (NSCLC) is considerably higher in Norway compared to Denmark, even though diagnostic work-up, treatment, and follow-up are comparable. We aim to explore factors behind favorable long-term survival for lung cancer patients in Norway compared to Denmark.
Method: A retrospective cohort study of patients with NSCLC diagnosed between 2014 and 2016.
Background And Purpose: Multi-disciplinary Team (MDT) meetings are widely regarded as the 'gold standard' of lung cancer care. MDTs improve adherence to clinical guidelines for lung cancer patients. In this study, we describe and compare lung cancer MDTs in Denmark and Norway by combining national surveys and the MDT-Metric for the Observation of Decision-making (MDT-MODe) instrument.
View Article and Find Full Text PDFBackground: The fast-track cancer pathway aims to expedite diagnosis of lung cancer and treatment and is the preferred route to diagnosis. Diagnosis following an unplanned admission (unplanned route) has been associated with poor outcomes.
Objective: This study explores factors associated with lung cancer diagnosis following unplanned admissions, focusing on the elderly population.
Article Synopsis
- - The study focuses on understanding the characteristics, diagnostic processes, treatment patterns, and survival rates of elderly lung cancer patients in Denmark, specifically aiming to address the under-representation of older individuals in clinical trials.
- - An analysis of 17,835 lung cancer patients showed that only 16.1% were aged 80 and over, and these elderly patients had lower rates of diagnostic procedures and curative treatments compared to younger patients.
- - Findings revealed that elderly patients had significantly higher odds (2.1 times) of dying within 12 months of diagnosis, indicating that older age is linked to worse outcomes in lung cancer treatment and prognosis.